- Home
- NRIX vs VERX Comparison
NRIX vs VERX Comparison
Compare NRIX & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | VERX |
|---|---|---|
| Founded | 2009 | 1978 |
| Country | United States | United States |
| Employees | 357 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NRIX | VERX |
|---|---|---|
| Price | $23.38 | $11.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $30.50 | $24.25 |
| AVG Volume (30 Days) | 1.6M | ★ 1.8M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $76,987,000.00 | ★ $748,444,000.00 |
| Revenue This Year | N/A | $12.78 |
| Revenue Next Year | $48.05 | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | ★ 99.31 | 12.25 |
| 52 Week Low | $8.20 | $10.21 |
| 52 Week High | $25.09 | $34.54 |
Technical Indicators
Market Signals| Indicator | NRIX | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 45.42 |
| Support Level | $14.63 | $11.58 |
| Resistance Level | $24.98 | $13.50 |
| Average True Range (ATR) | 1.21 | 0.65 |
| MACD | -0.26 | -0.14 |
| Stochastic Oscillator | 52.40 | 32.25 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.